The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome

被引:1
作者
Piacentino, Daria [1 ,2 ,3 ]
Cesarini, Monica [4 ]
Badiali, Danilo [4 ]
Pallotta, Nadia [4 ]
Biondi, Massimo [5 ]
Corazziari, Enrico Stefano [4 ,6 ]
机构
[1] Sapienza Univ Rome, St Andrea Hosp, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, Rome, Italy
[2] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, DICBR, Bethesda, MD 20892 USA
[3] NIDA, IRP, NIH, Bethesda, MD 20892 USA
[4] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Policlin Umberto I, Rome, Italy
[5] Sapienza Univ Rome, Dept Human Neurosci, Policlin Umberto I, Rome, Italy
[6] Humanitas Clin Inst, Dept Gastroenterol, Milan, Italy
关键词
Inflammatory bowel disease; irritable bowel syndrome; psychopathology; Symptom Checklist-90-Revised; disease severity; QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; CROHNS-DISEASE; PSYCHIATRIC-ILLNESS; ULCERATIVE-COLITIS; SWEDISH PATIENTS; ANXIETY; DEPRESSION; IMPACT; IBS;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background. Biopsychosocial models for both organic and functional gastrointestinal (GI) disorders can be found in the literature. To clarify the role of psychopathological factors and their relationship with GI symptom severity, several studies have examined them in inflammatory bowel disease (IBD) - occasionally distinguishing between ulcerative colitis (UC) and Crohn's disease (CD) - and in irritable bowel syndrome (IBS), leading to unclear results. Aims. We aimed to evaluate the psychopathological features of IBD and IBS patients in comparison with healthy individuals and assess the association with disease severity. Materials and methods. Sixty-nine IBD outpatients, of which 35 UC and 34 CD, and 75 IBS ones were consecutively recruited at the third level Gastroenterological Center of our University Hospital; 76 healthy controls were also recruited. The psychological status was assessed with the Symptom Checklist-90-Revised (SCL-90-R). Results. IBD and IBS patients showed significantly higher scores on the SCL-90-R Global Severity Index (GSI) and subscales than controls (all p-values<0.001), and IBS patients showed significantly higher GSI, depression, and anxiety scores than IBD patients (all p-values<0.01). Psychopathology was comparable between UC and CD patients. In IBD and IBS patients the SCL-90-R GSI was significantly associated with disease severity (p<0.001). Conclusions. The presence of chronic bowel symptoms, either organic or functional, is linked to a greater severity of psychopathology compared to the general population, possibly as a consequence of higher loads of stress due to the symptoms affecting everyday life. In both IBD and IBS patients, greater disease severity and worse psychopathological functioning are related.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 50 条
  • [31] Irritable Bowel Syndrome on Inflammatory Bowel Disease in Deep Remission: No Relation with Remission Deepening and Inflammation
    Sezgin, Orhan
    Boztepe, Burcu
    Ucbilek, Enver
    Altintas, Engin
    Celikcan, Havva Didem
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (10) : 870 - 878
  • [32] Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression
    Perera, Lilani P.
    Radigan, Mark
    Guilday, Corinne
    Banerjee, Indrani
    Eastwood, Daniel
    Babygirija, Reji
    Massey, Benson T.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (07) : 1923 - 1928
  • [33] The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission
    Hoekman, Daniel R.
    Zeevenhooven, Judith
    D'Haens, Geert R.
    Benninga, Marc A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (09) : 1086 - 1090
  • [34] Irritable Bowel Syndrome in Inflammatory Bowel Disease
    Ryu, Ki-Hyun
    Huh, Kyu-Chan
    INTESTINAL RESEARCH, 2010, 8 (02) : 95 - 105
  • [35] A Pilot Study of Clinical Evaluation and Formation Mechanism of Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease Patients in Remission
    Wang, Haiyang
    Zhao, Xiaojing
    Cui, Xiufang
    Wang, Meifeng
    Jiao, Chunhua
    Li, Jiajia
    Yang, Yan
    Li, Yi
    Zhang, Hongjie
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 27 (04) : 612 - 625
  • [36] (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review
    Hagan, Marilyn
    Hayee, Bu' Hussain
    Rodriguez-Mateos, Ana
    MOLECULES, 2021, 26 (07):
  • [37] Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease
    Camilleri, Michael
    GUT, 2011, 60 (04) : 425 - 428
  • [38] PATHOPHYSIOLOGY OF IRRITABLE BOWEL SYNDROME IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE
    Oliveira, Diego Brandao
    Carvalho, Naiara Salgado
    dos Anjos, Gabriele Alves
    Silva, Genoile Oliveira Santana
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S72 - S72
  • [39] Lower gastric sensitivity in quiescent inflammatory bowel disease than in irritable bowel syndrome
    Schulz, Andre
    Welsch, Sina-Katharina
    Etringer, Sarah
    Hansen, Greta
    Milbert, Lea
    Schneider, Jochen
    Taddei, Gennaro
    Bravo, Raquel Gomez
    Lygidakis, Charilaos
    van Dyck, Zoe
    Lutz, Annika
    Wilmes, Paul
    Vogele, Claus
    PHYSIOLOGY & BEHAVIOR, 2023, 270
  • [40] Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease
    Tomita, Toshihiko
    Kato, Yu
    Takimoto, Mayu
    Yamasaki, Takahisa
    Kondo, Takashi
    Kono, Tomoaki
    Tozawa, Katsuyuki
    Yokoyama, Yoko
    Ikehara, Hisatomo
    Ohda, Yoshio
    Oshima, Tadayuki
    Fukui, Hirokazu
    Tanaka, Shigemi
    Shima, Masayuki
    Watari, Jiro
    Miwa, Hiroto
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (04) : 661 - 669